Hu Kaiqiang, Secretary-General of the Shanghai Cooperation Organization Countries Multifunctional Economic and Trade Platform and Deputy Director of the Hong Kong, Macao, Taiwan, Overseas Chinese and Foreign Affairs Committee of the Chongqing CPPCC, welcomes Zhu Zhaojing and his delegation.
At the same time, as a specially appointed expert at the Chongqing Institute of Medicinal Plant Cultivation, Professor Zhu Zhaojing expressed appreciation for the platform's positive role in promoting economic and trade cooperation and cultural exchanges between China and other SCO and "Belt and Road" countries. He stated his hope to strengthen interaction with the platform to actively contribute to international cooperation and exchange in traditional Chinese medicine and the big health sector among SCO countries.
In view of Professor Zhu Zhaojing's professional achievements in drug production, new drug research, pharmaceutical education, traditional Chinese medicine, and big health, and upon recommendation by the platform's Traditional Chinese Medicine Digital Health Working Committee, the platform's research decision appointed Professor Zhu Zhaojing as Senior Professional Advisor of the Shanghai Cooperation Organization Countries Multifunctional Economic and Trade Platform Think Tank, and held a certificate awarding ceremony.
Zhu Zhaojing is a specially appointed expert at the Chongqing Institute of Medicinal Plant Cultivation, former Chief Engineer and Associate Researcher at the Sichuan Institute of Traditional Chinese Medicine Pharmaceutical Factory, former Professor and Director of the Teaching and Research Office at the School of Pharmacy, Chongqing Medical University, and former Professor and Vice President of Chongqing Medical and Pharmaceutical College. He has engaged in new drug research, traditional Chinese medicine preparation and processing research, drug production, drug inspection, and pharmaceutical education for 42 years, leading and participating in over 160 research projects. He holds one new drug certificate and one clinical approval; has applied for 68 Chinese patents, including 42 invention patents and 12 utility model patents, with 24 authorized; published 168 papers, including 64 CSCD and 38 SCI papers. He participated in formulating 3 national drug standards; edited 3 monographs and 9 textbooks. He has won 2 second prizes for national teaching achievements, 2 first prizes for Chongqing teaching achievements, and 1 third prize for Chongqing scientific and technological progress; recognized as a Chongqing teaching master and a reserve candidate for Chongqing academic and technical leaders.
